Tristel plc (AIM: TSTL)

Market Cap	205.93M
Revenue (ttm)	39.49M
Net Income (ttm)	6.04M
Shares Out	47.61M
EPS (ttm)	0.13
PE Ratio	34.46
Forward PE	34.64
Dividend	0.11 (2.42%)
Ex-Dividend Date	Mar 21, 2024

Volume	6,930
Open	430.50
Previous Close	434.00
Day's Range	430.00 - 433.00
52-Week Range	360.00 - 510.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 14, 2024

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 208
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: TSTL

Financial Performance

In 2023, Tristel's revenue was 36.01 million, an increase of 15.70% compared to the previous year's 31.12 million. Earnings were 4.46 million, an increase of 351.98%.